STUELPNAGEL JOHN R — SEC Form 4 filings

SEC reporting owner CIK 1189140. 5 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-06-13 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
10x Genomics, Inc. (TXG)Director55 legs · 40,000 sh · $2,390,1273

Form 4 filings — STUELPNAGEL JOHN R

FiledFormIssuerReported transactionsSource
2026-09-08410x Genomics, Inc. (TXG)Sale (S): 7,012 @ $60.66 · Sale (S): 6,814 @ $62.11 · Sale (S): 6,174 @ $62.61EDGAR
2026-08-13410x Genomics, Inc. (TXG)Sale (S): 17,000 @ $57.58 · Sale (S): 3,000 @ $58.73EDGAR
2026-06-08410x Genomics, Inc. (TXG)Grant/award (A): 8,829 @ $0EDGAR
2025-06-05410x Genomics, Inc. (TXG)Grant/award (A): 15,357 @ $0EDGAR
2024-06-13410x Genomics, Inc. (TXG)Grant/award (A): 8,649 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1189140 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →